This includes some form of cancers where tumor cells are resistant to chemotherapeutic agents due to the increased expression of anti-apoptotic Bcl-xL and diabetes where β-cells undergo apoptosis correlating to a shift in the splicing ratio to promote the pro-apoptotic Bcl-xS isoform relative to Bcl-xL. Here, BCL2L1 is linked to cancer.